KENNETH OSIEZAGHA: Open Payments
NPI 1205181724 · LAKE JACKSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,406 in 167 payments from 18 companies in 2025. Trend: 2023 $2,185 · 2024 $8,773 · 2025 $2,406
Food & beverage: $2,406
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $487 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 37 | $463 |
| Otsuka America Pharmaceutical, Inc. | 17 | $202 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $199 |
| Axsome Therapeutics, Inc. | 13 | $193 |
| Alkermes, Inc. | 12 | $177 |
| Lundbeck LLC | 10 | $155 |
| Corium, LLC | 6 | $88 |
| Teva Pharmaceuticals USA, Inc. | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
Products named: VRAYLAR, CAPLYTA, REXULTI, TRINTELLIX, Auvelity, ARISTADA, Azstarys, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
